Yahoo
OTC Markets OTCID USD

CBD Life Sciences Inc. (CBDL)

0.0002 0.0000 (0.00%)
As of October 30 at 5:00:00 PM EDT. Market Open.
Chart Range Bar
Loading chart for CBDL
  • Previous Close 0.0002
  • Open 0.0001
  • Bid 0.0001 x 54000000
  • Ask 0.0002 x 15013034900
  • Day's Range 0.0001 - 0.0001
  • 52 Week Range 0.0001 - 0.0005
  • Volume 16,580,713
  • Avg. Volume 8,818,140
  • Market Cap (intraday) 1.222M
  • Beta (5Y Monthly) 86.74
  • PE Ratio (TTM) --
  • EPS (TTM) 0.0000
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

CBD Life Sciences Inc. engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include such as hemp drops, recovery pain relief products, anxiety and sleep solutions, supplements, edibles, bath products, kosher products, and a full line of pet products. CBD Life Sciences Inc. formerly known as Optium Cyber Systems, Inc. and Optium Cyber Systems, Inc. changed its name as CBD Life Sciences Inc. in January 2019. The company is based in Scottsdale, Arizona.

www.thecbdvault.com

3

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

CBDL
0.00%
S&P 500 (^GSPC)
10.99%

1-Year Return

CBDL
0.00%
S&P 500 (^GSPC)
11.08%

3-Year Return

CBDL
99.33%
S&P 500 (^GSPC)
75.97%

5-Year Return

CBDL
99.67%
S&P 500 (^GSPC)
64.08%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY18
Revenue 150k
Earnings 38.3k
Profit Margin 25.53%

Q1

FY18

0
50K
100K
150K
25.5%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -49.76%

  • Return on Assets (ttm)

    -10.81%

  • Return on Equity (ttm)

    -8.71%

  • Revenue (ttm)

    98.32k

  • Net Income Avi to Common (ttm)

    -48.93k

  • Diluted EPS (ttm)

    0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    331.6k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -53.68k

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: